Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval.
- DOI
- 10.1016/j.clgc.2022.12.009
- Published
- 2023 Jun
- Container
- Clinical genitourinary cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clgc.2022.12.009,
title = {Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval.},
author = {Nemirovsky DR and Klose C and Wynne M and McSweeney B and Luu J and Chen J and Atienza M and Waddell B and Taber B and Haji-Momenian S and Whalen MJ},
year = {2023},
journal = {Clinical genitourinary cancer},
doi = {10.1016/j.clgc.2022.12.009},
url = {https://doi.org/10.1016/j.clgc.2022.12.009}
}RIS
TY - JOUR TI - Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval. AU - Nemirovsky DR AU - Klose C AU - Wynne M AU - McSweeney B AU - Luu J AU - Chen J AU - Atienza M AU - Waddell B AU - Taber B AU - Haji-Momenian S AU - Whalen MJ PY - 2023 JO - Clinical genitourinary cancer DO - 10.1016/j.clgc.2022.12.009 UR - https://doi.org/10.1016/j.clgc.2022.12.009 ER -
APA
DR, N., C, K., M, W., B, M., J, L., J, C., M, A., B, W., B, T., S, H., & MJ, W. (2023). Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval.. Clinical genitourinary cancer. https://doi.org/10.1016/j.clgc.2022.12.009
Source records
- pubmed · retrieved 2026-09-26T17:35:34.416Z